Arrowhead Pharmaceuticals
Clinical trials sponsored by Arrowhead Pharmaceuticals, explained in plain language.
-
New shot could help teens with rare, severe high cholesterol
Disease control Not yet recruitingThis study tests a new drug called zodasiran in 12 teens aged 12 to 17 with homozygous familial hypercholesterolemia, a rare genetic condition causing very high cholesterol. The drug is given as a shot under the skin. The main goal is to see if it safely lowers bad cholesterol af…
Phase: PHASE3 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
First human doses of experimental drug ARO-033 begin safety testing
Knowledge-focused Not yet recruitingThis study is the first time the experimental drug ARO-033 is being given to humans. Its main goal is to check the safety and tolerability of single and multiple doses in healthy adult volunteers. Researchers will also measure how the drug moves through the body. This is an early…
Phase: PHASE1 • Sponsor: Arrowhead Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC